A First-in-Human, Phase I, Dose-Escalation Study of...

  • Main
  • 2017 / 05
  • A First-in-Human, Phase I, Dose-Escalation Study of...
Clinical Cancer Research 2017 / 05

A First-in-Human, Phase I, Dose-Escalation Study of TAK-117, a Selective PI3Kα Isoform Inhibitor, in Patients with Advanced Solid Malignancies

Juric, Dejan, de Bono, Johann S, LoRusso, Patricia M., Nemunaitis, John, Heath, Elisabeth I, Kwak, Eunice L., Macarulla Mercadé, Teresa, Geuna, Elena, Jose de Miguel-Luken, Maria, Patel, Chirag, Kuida
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-16-2888
Date:
May, 2017
File:
PDF, 9.88 MB
english, 2017
Conversion to is in progress
Conversion to is failed